- Home
- ARQT vs CWH Comparison
ARQT vs CWH Comparison
Compare ARQT & CWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | CWH |
|---|---|---|
| Founded | 2016 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 363.8M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ARQT | CWH |
|---|---|---|
| Price | $25.11 | $4.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $37.00 | $10.40 |
| AVG Volume (30 Days) | ★ 2.6M | 1.9M |
| Earning Date | 10-27-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | 0.03 | ★ 3.99 |
| Revenue | $376,072,000.00 | ★ $4,792,017,000.00 |
| Revenue This Year | $42.88 | N/A |
| Revenue Next Year | $27.84 | $4.75 |
| P/E Ratio | $843.00 | ★ $1.26 |
| Revenue Growth | ★ 91.34 | 11.83 |
| 52 Week Low | $19.30 | $4.79 |
| 52 Week High | $31.77 | $17.15 |
Technical Indicators
Market Signals| Indicator | ARQT | CWH |
|---|---|---|
| Relative Strength Index (RSI) | 47.03 | 26.43 |
| Support Level | $24.91 | N/A |
| Resistance Level | $28.20 | $6.95 |
| Average True Range (ATR) | 1.48 | 0.35 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 39.98 | 23.31 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About CWH Camping World Holdings Inc.
Camping World Holdings Inc is a retailer of RVs and related products and services. The company offers RV products and services with a national network of RV dealerships, service centers and customer support centers. It operates in two reportable segments: Good Sam Services and Plans; and RV and Outdoor Retail. The majority of the revenue is derived from RV and Outdoor Retail segment that derives revenue from the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, and supplies; the sale of outdoor products, equipment, gear and supplies; and the sale of Good Sam Club memberships and co-branded credit cards.